series-b
Stage
4
Investors
About
Stilla Technologies develops digital PCR hardware systems that enable absolute quantification and multiplex analysis for use in genetic research and diagnostic applications.
Explore Stilla Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.